Kingsview Wealth Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.63M Sell
71,823
-20,103
-22% -$1.23M 0.04% 406
2026
Q1
$6M Sell
91,926
-497
-0.5% -$36.4K 0.08% 264
2025
Q4
$7.44M Sell
92,423
-19,338
-17% -$1.55M 0.11% 184
2025
Q3
$9.17M Buy
+111,761
New +$9.69M 0.14% 143
2025
Q2
Sell
-31,582
Closed -$2.89M 1181
2025
Q1
$2.89M Buy
+31,582
New +$2.76M 0.05% 304
2022
Q4
Sell
-6,133
Closed -$487K 856
2022
Q3
$487K Buy
+6,133
New +$520K 0.02% 510
2021
Q3
Sell
-10,191
Closed -$805K 909
2021
Q2
$805K Buy
+10,191
New +$787K 0.04% 428

Other funds holding DOX

Kingsview Wealth Management's DOX Position: Q2 2026 in Review

Kingsview Wealth Management reduced its Amdocs (DOX) stake by 22% in Q2 2026, selling an estimated $1.23M and leaving 71,823 shares worth $3.63M. The position accounts for 0.04% of the portfolio, ranked #406.

Kingsview Wealth Management first reported a position in DOX in Q2 2021 and has held it in 7 quarters since. The position peaked at $9.17M in Q3 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Kingsview Wealth Management held 71,823 shares of Amdocs worth $3.63M as of Q2 2026.
  • Kingsview Wealth Management sold 20,103 Amdocs shares in Q2 2026, an estimated $1.23M.
  • Amdocs made up 0.04% of Kingsview Wealth Management's portfolio in Q2 2026, its #406 holding.
  • Kingsview Wealth Management first reported a position in Amdocs in Q2 2021 and has held it in 7 quarters since.
  • Kingsview Wealth Management's Amdocs position peaked at $9.17M in Q3 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.